#psychiatric evaluation

[babiezomb]

psych eval pt 1

[my-adhd-diaries]

ADHD Adventures #16

My First Co-morbid

So in order for my IEP to be valid in university next year, I had to get re-evaluated.

During this process we discovered that not only do I have ADHD combined type (knew that already) but ya girl also has Generalized Anxiety Dissorder.

I’ve known that something wasn’t right with my mental health for a long time, but I couldn’t get my parents to take me seriously, so it actually feels really good to finally know:

That I’m not crazy

What’s actually going on with me

[onfirewhenifoundit]

I had two appointments with a psychiatric gatekeeper for top surgery last month, the second of which was the kind of experience that makes people say “yeah, I don’t do therapy”.

My own therapist, after speaking with the professional in question (who wanted to speak to my therapist as a routine background check) said that his initial feelings when I related the experience to him were confirmed; the gatekeeper actually knew almost nothing about gender transition.  He added that he had sort of lost sight of the fact that many mental health professionals, when confronted with a gender-questioning or trans person, can’t stop looking for some source of trauma or disorder which would explain their transness.  Because, of course, trans people have to be broken in some way, right?  A lot of cisgender mental health people just can’t wrap their heads around the notion that someone can be transgender and otherwise psychologically sound (well, other than the stress of not conforming).

I’m not trans because I was sexually abused as a child.  I’m not trans because I was bullied in school.  I was always this way. I was born a different gender than the one arbitrarily assigned to me based on initial physical characteristics.  It’s only recently that I found the language and social structures to explain to other people who I really am.  I’m just as sane as I’ve always been.  More, even, now that I’m at peace with myself.

[thisisdefinitelyaboutyou-blog]

I’m neither hypersexual nor suicidal today. That’s a first this week!

I have an evaluation with my psychiatrist today. 

Things I intend on bringing up is during the session include:

excessive preoccupation with thoughts about death (in general; unrelated to myself)

less frequent thoughts of suicidal ideation

periodical, extreme sexual impulses, mainly driven by thoughts about Bob

Obsessive thoughts about Bob

Possible delusions about my diagnosis

My psychologists offer to administer the Million test

[ohiopsychiatricservice]

What Is Esketamine? A Complete Guide to Spravato Treatment

Esketamine is an FDA-approved nasal spray for adults with depression that hasn’t responded to other treatments. It comes from the same family as ketamine, though it isn’t the same as the ketamine infusions you might have seen advertised elsewhere — a difference worth understanding before you go any further.

It exists because standard antidepressants don’t work for everyone. Around one in three people with depression don’t get real relief from the usual medications, and waiting weeks to find out if yet another pill will help isn’t just discouraging — for some people, it’s genuinely risky. Esketamine works through a different pathway in the brain, and as of January 2025, it can be used on its own or alongside an antidepressant you’re already taking. That’s new flexibility that didn’t exist before.

Here’s everything worth knowing: who it’s actually for, what happens during treatment, what the research and the doctors who prescribe it are saying, how it stacks up against other options, and the side effects worth being aware of.

Who Is Eligible for Esketamine Treatment?

Esketamine isn’t usually a first step, and it isn’t for everyone with depression. It’s approved for two specific situations.

The first is treatment-resistant depression — meaning you’ve genuinely tried at least two different antidepressants, at a real dose, for a real stretch of time, and neither one helped enough. If that’s your story, esketamine may be worth a serious conversation with a psychiatrist. Since 2025, you can take it either alone or alongside your current antidepressant, whichever fits your situation better.

The second is depression that comes with suicidal thoughts. This is one of the reasons esketamine matters so much to the people who prescribe it — it can work within a day or two, which is a meaningful difference when someone is in real distress and every week of waiting counts.

Beyond diagnosis, your doctor will also want to know a few other things before moving forward. Blood pressure that’s hard to control matters, since esketamine can raise it temporarily. So does a history of aneurysms or certain heart and blood vessel conditions. If substance use involving ketamine or similar drugs has ever been part of your history, that’s worth an honest conversation too, and the same goes for pregnancy or breastfeeding.

None of this is meant to be a checklist that disqualifies you on the spot — it’s simply what a good doctor needs to know to make this decision safely, together with you.

Know More About:

Is Esketamine Right for You? A Guide to Treatment-Resistant Depression

Why you should consider TMS & Esketamine Therapy for Depression

What to Expect: Your First Session to Ongoing Treatment

Esketamine isn’t a prescription you pick up and take at home. Every dose happens inside a certified clinic, under supervision — that’s a federal requirement, not just how one clinic chooses to do things.

Before your first session, your provider will go over your medical history, check your current medications and blood pressure, and make sure you have a ride home, since you won’t be allowed to drive yourself afterward. During the session, you’ll spray the medication yourself while a healthcare provider watches over you — usually two doses a few minutes apart. Including the time you’re monitored afterward, the whole appointment takes around two hours.

That monitoring period matters. You’ll stay at the clinic for at least two hours after your dose while staff check your blood pressure and make sure any sedation or dissociation has worn off before you leave.

In terms of how often, treatment starts intensively and then eases off. For the first four weeks, sessions happen twice a week. From weeks five through eight, that drops to once a week, and after that, most people move to a session every one to two weeks, depending on how they’re doing. Whether you keep taking an oral antidepressant alongside this depends on which approach you and your doctor choose.

How Esketamine Actually Works

Esketamine is essentially one half of the ketamine molecule — the S-enantiomer, if you want the technical term — purified and turned into a nasal spray. That’s what “intranasal esketamine” means, and it’s what allows for precise, repeatable dosing without an IV.

Most antidepressants, like SSRIs and SNRIs, work by adjusting serotonin and norepinephrine, and they typically take four to eight weeks to show their full effect. Esketamine takes a completely different route. It blocks a receptor called NMDA, which plays a role in glutamate signaling in the brain. Researchers believe this encourages the brain to build new connections between neurons, which may be why so many patients notice a shift in mood within 24 hours instead of weeks.

That different mechanism is also why people notice something happening during the session itself — a temporary sense of detachment from their surroundings, drowsiness, or changes in perception. These effects are expected and short-lived, which is exactly why the two-hour monitoring window exists.

What Experts and Clinical Trials Say

None of this is based on marketing claims — esketamine’s approval came from FDA-reviewed trials, and researchers have kept studying it since it first came to market in 2019.

A 2025 review that looked across several major trials — TRANSFORM-2, SUSTAIN-1, and ASPIRE I and II — found that esketamine tends to work quickly, often within hours, and improves both remission and response rates for people with treatment-resistant depression. The trial that supported the 2025 monotherapy approval backed this up: esketamine alone showed a statistically significant improvement over placebo at four weeks, and in a separate look at the same data, 22.5% of patients reached remission by that point, compared with 7.6% on placebo.

The doctors who actually prescribe esketamine have been fairly candid about it, too — both the good and the complicated parts. Dr. Gregory Mattingly, President of Midwest Research Group, said the 2025 monotherapy approval gives providers “the freedom to further personalize treatment plans” for their patients. But it’s not all upside from a clinical standpoint. A review of how mental healthcare providers talk about esketamine found real enthusiasm for how fast it works, alongside genuine concerns — the monitoring requirements, the cost (which can run into the thousands of dollars in the first month), and the extra staff and space clinics need to offer it responsibly.

Guideline groups have echoed a similar, balanced message. The American Psychological Association’s 2025 guidance on treatment-resistant depression recommends a careful, step-by-step approach — reassessing the diagnosis and making sure prior antidepressants were given a fair shot before moving on to something like esketamine.In plain terms: this is a strong option for the right person, at the right point in their treatment journey, not something meant to replace everything that came before it.

Esketamine vs. Your Other Options

It’s natural to wonder how this compares with what you’ve already tried, or with other treatments you’ve heard about. Every option trades off speed, how invasive it is, how easy it is to access, and how much evidence backs it up. Here’s how the main ones stack up, side by side:

A few things genuinely set esketamine apart. It tends to work faster than any oral medication, often in days rather than weeks. It’s also far more standardized than off-label IV ketamine — the dosing, the safety checks, and the monitoring are all set by the FDA, not left up to whichever clinic you walk into. And since 2025, it offers something none of the others do quite the same way: the choice to use it alone or alongside your current antidepressant. Compared with ECT, it also asks much less of you physically — no general anesthesia, no induced seizure, and far less disruption to memory and daily life for most people.

That said, esketamine isn’t automatically the “best” choice in every case. ECT still has some of the highest remission rates for the most severe depression, and TMS skips sedation and monitoring requirements altogether. The honest answer is that esketamine is a strong fit for a specific group of people — not a blanket upgrade over everything else.

Benefits of Esketamine Treatment

Put simply, for the people it’s approved for, esketamine tends to offer:

Faster relief than most oral antidepressants, often within a day or two

A different way of working in the brain, useful when serotonin-based medicine hasn’t helped

A structured, supervised process, so there’s less guesswork around dosing

Flexibility to use it alone or with your current antidepressant

A meaningful option when suicidal thoughts make speed genuinely matter

Not everyone responds the same way, and it isn’t a guaranteed fix — but for people who’ve run out of other options, it can genuinely change how quickly relief arrives.

Esketamine Side Effects & Safety

Esketamine, like any psychiatric medication, has real side effects, and it carries the FDA’s most serious safety label — a boxed warning — covering sedation, dissociation, and the potential for misuse.

The most common things people notice during and shortly after a session include feeling disconnected from reality, drowsiness, dizziness or vertigo, a temporary rise in blood pressure, nausea, anxiety, and a general feeling of intoxication. These usually fade fairly quickly, which is exactly why the two-hour monitoring window is built into every session at Ohio Psychiatric Services.

It’s also worth knowing that cost can be a real barrier — sometimes running into the thousands of dollars for the first month — and that long-term safety data is still limited for people who may need this treatment indefinitely. Both are worth raising directly with your provider and your insurance plan before you begin. For more information on what to expect or to discuss whether esketamine treatment is right for you, 

If you’ve tried multiple antidepressants and still don’t feel like yourself, it can be discouraging and exhausting. Treatment‑resistant depression (TRD) is more common than many people realize, and it does not mean you have run out of options or it is a sign that you are not trying hard enough. Advances in depression treatment, including Spravato (esketamine), are offering renewed hope to individuals who have struggled to find relief through traditional approaches.

If you’ve tried multiple antidepressants and still don’t feel like yourself, it can be discouraging and exhausting. Treatment‑resistant depression (TRD) is more common than many people realize, and it does not mean you have run out of options or it is a sign that you are not trying hard enough. Advances in depression treatment, including Spravato (esketamine), are offering renewed hope to individuals who have struggled to find relief through traditional approaches.

If you’ve tried multiple antidepressants and still don’t feel like yourself, it can be discouraging and exhausting. Treatment‑resistant depression (TRD) is more common than many people realize, and it does not mean you have run out of options or it is a sign that you are not trying hard enough. Advances in depression treatment, including Spravato (esketamine), are offering renewed hope to individuals who have struggled to find relief through traditional approaches.

Spravato (esketamine) nasal spray was developed specifically for adults in this situation. It is the only FDA‑approved nasal spray for treatment‑resistant depression and can be used on its own or alongside an oral antidepressant. For people seeking advanced depression treatment or alternatives to antidepressants in Columbus, Ohio area, understanding how Spravato works and what the research shows can make next steps feel clearer and more hopeful.

How Spravato Works in the Brain

Most antidepressants gradually change serotonin or norepinephrine levels and often take several weeks to work. Spravato targets a different system: the glutamate pathway.

Esketamine briefly blocks NMDA receptors, triggering a surge of glutamate and activating AMPA receptors. This increases a growth factor (BDNF) that supports neuroplasticity, the brain’s ability to form new, healthier connections. In depression, brain pathways can become rigid and locked into negative patterns. Spravato helps interrupt those patterns and gives your brain a chance to ‘reset’ and build new routes instead of staying stuck in the same loop.

Because it acts directly on these circuits, some patients notice a shift in symptoms within hours to days, rather than waiting weeks as with standard antidepressants alone.

How Quickly Spravato Starts to Work

A key difference between Spravato and many oral antidepressants is speed. While typical medications may take four to six weeks to show full effect, Spravato often acts sooner.

Many people experience a pattern like this:

Within 24 hours: Some patients report subtle improvements, such as feeling less overwhelmed or experiencing a much lower intensity of their symptoms or reduced suicidal thinking.

First 1–2 weeks: Improvements become more consistent as the brain responds to repeated doses.

By about 4 weeks: During the induction phase, many patients see more stable and significant relief.

Each person’s course is unique. How long you have been depressed, what you have already tried, other medical conditions, and whether you are also in therapy or TMS will all influence how quickly and how strongly you respond.

What the Evidence Shows

Clinical trials and real‑world data show that Spravato can bring meaningful relief to adults with treatment‑resistant depression who have not improved enough with at least two antidepressants. These results are especially important because they come from a group that is often hardest to treat.

Studies have found:

Rapid symptom reduction for many patients within the first month.

Some individuals notice benefit within 24 hours of the first dose.

Patients who continue Spravato as maintenance treatment are less likely to relapse than those who stop after an initial response.

People who respond often describe clearer thinking, better energy, renewed interest in activities, and a stronger ability to connect with others, not just a small lift in mood.

What Spravato Treatment Looks Like at OPS

Esketamine is an FDA-approved nasal spray for adults with depression that hasn’t responded to other treatments. It comes from the same family as ketamine, though it isn’t the same as the ketamine infusions you might have seen advertised elsewhere — a difference worth understanding before you go any further.

It exists because standard antidepressants don’t work for everyone. Around one in three people with depression don’t get real relief from the usual medications, and waiting weeks to find out if yet another pill will help isn’t just discouraging — for some people, it’s genuinely risky. Esketamine works through a different pathway in the brain, and as of January 2025, it can be used on its own or alongside an antidepressant you’re already taking. That’s new flexibility that didn’t exist before.

Here’s everything worth knowing: who it’s actually for, what happens during treatment, what the research and the doctors who prescribe it are saying, how it stacks up against other options, and the side effects worth being aware of.

Who Is Eligible for Esketamine Treatment?

Esketamine isn’t usually a first step, and it isn’t for everyone with depression. It’s approved for two specific situations.

The first is treatment-resistant depression — meaning you’ve genuinely tried at least two different antidepressants, at a real dose, for a real stretch of time, and neither one helped enough. If that’s your story, esketamine may be worth a serious conversation with a psychiatrist. Since 2025, you can take it either alone or alongside your current antidepressant, whichever fits your situation better.

The second is depression that comes with suicidal thoughts. This is one of the reasons esketamine matters so much to the people who prescribe it — it can work within a day or two, which is a meaningful difference when someone is in real distress and every week of waiting counts.

Beyond diagnosis, your doctor will also want to know a few other things before moving forward. Blood pressure that’s hard to control matters, since esketamine can raise it temporarily. So does a history of aneurysms or certain heart and blood vessel conditions. If substance use involving ketamine or similar drugs has ever been part of your history, that’s worth an honest conversation too, and the same goes for pregnancy or breastfeeding.

None of this is meant to be a checklist that disqualifies you on the spot — it’s simply what a good doctor needs to know to make this decision safely, together with you.

Know More About:

Is Esketamine Right for You? A Guide to Treatment-Resistant Depression

Why you should consider TMS & Esketamine Therapy for Depression

What to Expect: Your First Session to Ongoing Treatment

Esketamine isn’t a prescription you pick up and take at home. Every dose happens inside a certified clinic, under supervision — that’s a federal requirement, not just how one clinic chooses to do things.

Before your first session, your provider will go over your medical history, check your current medications and blood pressure, and make sure you have a ride home, since you won’t be allowed to drive yourself afterward. During the session, you’ll spray the medication yourself while a healthcare provider watches over you — usually two doses a few minutes apart. Including the time you’re monitored afterward, the whole appointment takes around two hours.

That monitoring period matters. You’ll stay at the clinic for at least two hours after your dose while staff check your blood pressure and make sure any sedation or dissociation has worn off before you leave.

In terms of how often, treatment starts intensively and then eases off. For the first four weeks, sessions happen twice a week. From weeks five through eight, that drops to once a week, and after that, most people move to a session every one to two weeks, depending on how they’re doing. Whether you keep taking an oral antidepressant alongside this depends on which approach you and your doctor choose.

How Esketamine Actually Works

Esketamine is essentially one half of the ketamine molecule — the S-enantiomer, if you want the technical term — purified and turned into a nasal spray. That’s what “intranasal esketamine” means, and it’s what allows for precise, repeatable dosing without an IV.

Most antidepressants, like SSRIs and SNRIs, work by adjusting serotonin and norepinephrine, and they typically take four to eight weeks to show their full effect. Esketamine takes a completely different route. It blocks a receptor called NMDA, which plays a role in glutamate signaling in the brain. Researchers believe this encourages the brain to build new connections between neurons, which may be why so many patients notice a shift in mood within 24 hours instead of weeks.

That different mechanism is also why people notice something happening during the session itself — a temporary sense of detachment from their surroundings, drowsiness, or changes in perception. These effects are expected and short-lived, which is exactly why the two-hour monitoring window exists.

What Experts and Clinical Trials Say

None of this is based on marketing claims — esketamine’s approval came from FDA-reviewed trials, and researchers have kept studying it since it first came to market in 2019.

A 2025 review that looked across several major trials — TRANSFORM-2, SUSTAIN-1, and ASPIRE I and II — found that esketamine tends to work quickly, often within hours, and improves both remission and response rates for people with treatment-resistant depression. The trial that supported the 2025 monotherapy approval backed this up: esketamine alone showed a statistically significant improvement over placebo at four weeks, and in a separate look at the same data, 22.5% of patients reached remission by that point, compared with 7.6% on placebo.

The doctors who actually prescribe esketamine have been fairly candid about it, too — both the good and the complicated parts. Dr. Gregory Mattingly, President of Midwest Research Group, said the 2025 monotherapy approval gives providers “the freedom to further personalize treatment plans” for their patients. But it’s not all upside from a clinical standpoint. A review of how mental healthcare providers talk about esketamine found real enthusiasm for how fast it works, alongside genuine concerns — the monitoring requirements, the cost (which can run into the thousands of dollars in the first month), and the extra staff and space clinics need to offer it responsibly.

Guideline groups have echoed a similar, balanced message. The American Psychological Association’s 2025 guidance on treatment-resistant depression recommends a careful, step-by-step approach — reassessing the diagnosis and making sure prior antidepressants were given a fair shot before moving on to something like esketamine.In plain terms: this is a strong option for the right person, at the right point in their treatment journey, not something meant to replace everything that came before it.

Esketamine vs. Your Other Options

It’s natural to wonder how this compares with what you’ve already tried, or with other treatments you’ve heard about. Every option trades off speed, how invasive it is, how easy it is to access, and how much evidence backs it up. Here’s how the main ones stack up, side by side:

A few things genuinely set esketamine apart. It tends to work faster than any oral medication, often in days rather than weeks. It’s also far more standardized than off-label IV ketamine — the dosing, the safety checks, and the monitoring are all set by the FDA, not left up to whichever clinic you walk into. And since 2025, it offers something none of the others do quite the same way: the choice to use it alone or alongside your current antidepressant. Compared with ECT, it also asks much less of you physically — no general anesthesia, no induced seizure, and far less disruption to memory and daily life for most people.

That said, esketamine isn’t automatically the “best” choice in every case. ECT still has some of the highest remission rates for the most severe depression, and TMS skips sedation and monitoring requirements altogether. The honest answer is that esketamine is a strong fit for a specific group of people — not a blanket upgrade over everything else.

Benefits of Esketamine Treatment

Put simply, for the people it’s approved for, esketamine tends to offer:

Faster relief than most oral antidepressants, often within a day or two

A different way of working in the brain, useful when serotonin-based medicine hasn’t helped

A structured, supervised process, so there’s less guesswork around dosing

Flexibility to use it alone or with your current antidepressant

A meaningful option when suicidal thoughts make speed genuinely matter

Not everyone responds the same way, and it isn’t a guaranteed fix — but for people who’ve run out of other options, it can genuinely change how quickly relief arrives.

Esketamine Side Effects & Safety

Esketamine, like any psychiatric medication, has real side effects, and it carries the FDA’s most serious safety label — a boxed warning — covering sedation, dissociation, and the potential for misuse.

The most common things people notice during and shortly after a session include feeling disconnected from reality, drowsiness, dizziness or vertigo, a temporary rise in blood pressure, nausea, anxiety, and a general feeling of intoxication. These usually fade fairly quickly, which is exactly why the two-hour monitoring window is built into every session at Ohio Psychiatric Services.

It’s also worth knowing that cost can be a real barrier — sometimes running into the thousands of dollars for the first month — and that long-term safety data is still limited for people who may need this treatment indefinitely. Both are worth raising directly with your provider and your insurance plan before you begin. For more information on what to expect or to discuss whether esketamine treatment is right for you, 

Step 1: Comprehensive evaluation

Your care starts with a psychiatric evaluation. A psychiatrist reviews your depression history, previous medications, current symptoms, and medical background to confirm whether Spravato is appropriate and safe. This visit is also a time to discuss your goals and concerns.

Step 2: Insurance review and approval

If Spravato appears to be a good fit, the OPS team helps with insurance verification and prior authorization. Many major insurance plans now provide coverage for Spravato for treatment‑resistant depression, when medical necessity criteria are met, although prior authorization is typically required. Trained staff will explain the expected costs and scheduling so you know what to expect.

Step 3: Induction phase (first month)

Once approved, you start the induction phase:

Treatments typically occur twice a week for four weeks.

You self‑administer the nasal spray in a private room under direct clinical supervision.

Doses are given in a sequence of sprays spaced a few minutes apart.

After dosing, you stay for at least two hours while staff monitor your blood pressure, level of alertness, and side effects.

Because Spravato can cause temporary sedation or dissociation, you will need a ride home and should not drive or operate machinery for the rest of the day. Spravato cannot be taken at home; all doses are given in a certified clinic under a REMS safety program.

Step 4: Maintenance phase

If you respond to Spravato, your psychiatrist will transition you to a maintenance schedule. Many people start with weekly sessions and then move to every one to two weeks as symptoms stabilize. The goal is to maintain progress with the lowest effective treatment frequency.

Spravato may be used on its own or combined with an oral antidepressant, allowing your provider to tailor your plan to your history, preferences, and side‑effect profile.

Side Effects and Safety

Most Spravato side effects are short‑lived and occur around the time of each treatment. Many people find side effects lessen as they continue treatment and become more familiar with the process. Common experiences include:

Feeling detached or floaty (dissociation)

Dizziness or unsteadiness

Nausea

Temporary rises in blood pressure

Sleepiness or fatigue

These are the main reasons treatment happens in a clinic with monitoring instead of at home. Some patients also describe the treatment experience as calming or reflective. Having a dedicated team present throughout the monitoring period often helps patients feel reassured and supported.

Spravato may not be right for everyone. Aneurysmal vascular disease, a history of brain hemorrhage (stroke), severe or uncontrolled hypertension or pregnancy may make other treatment options more suitable. Your OPS psychiatrist will review your medical history and current medications carefully before starting.

Why Consider Spravato at Ohio Psychiatric Services?

At OPS, Spravato is one part of a broader, personalized approach to depression care in Central Ohio. In addition to esketamine therapy, we also offer:

TMS therapy in Columbus and Hilliard, Ohio

Comprehensive medication management

Counseling and psychotherapy

Psychiatric evaluations

Genetic testing and other advanced options

This allows your treatment‑resistant depression plan in Columbus, Ohio to be built around you, not just a single medication or procedure. For some people, Spravato is the missing piece that finally moves the needle after years of trial and error. For others, it becomes a key part of a combined strategy that includes TMS, medication adjustments, and therapy.

If you have tried multiple medications and continue to struggle with depression, you do not have to navigate the next steps alone. The team at Ohio Psychiatric Services can help you determine whether Spravato, TMS, or another advanced treatment option may be right for you and create a personalized plan designed to help you regain hope and improve your quality of life.

[avatarbehavioralhealth]

Psychiatric evaluation services help assess emotional, behavioral, and mental health conditions through professional assessments and personalized treatment recommendations focused on stability, wellness, and improved quality of life. Avatar Behavioral Health provides compassionate psychiatric care. Call [phone]

[ohiopsychiatricservice]

Trusted Mental Health Clinic Serving Columbus Ohio and Surrounding Communities

Finding the right mental health clinic in Columbus Ohio is one of the most important steps toward reclaiming your emotional wellbeing and living a more balanced life. Ohio Psychiatric Services is a leading psychiatric care provider serving Columbus, Ohio and nearby communities, bringing together a skilled team of board-certified psychiatrists, nurse practitioners, physician assistants, licensed counselors, and support staff under one roof. Every patient who walks through our doors receives a thorough clinical evaluation followed by a fully personalized treatment plan designed around their specific symptoms, lifestyle, and long-term health goals. Our compassionate, patient-first approach ensures that no two care plans are alike, because no two patients are alike.

As a dedicated Mental health clinic Columbus Ohio residents rely on, we specialize in diagnosing and treating a comprehensive range of mental health conditions, including depression, anxiety, ADHD, bipolar disorder, PTSD, OCD, schizophrenia, panic disorder, insomnia, dementia, and substance use disorders. To address these conditions effectively, we offer a diverse menu of evidence-based treatment options such as psychiatric evaluations, medication management, Transcranial Magnetic Stimulation (TMS), Spravato® (esketamine) therapy, individual counseling, genetic testing, and flexible telehealth appointments. Whether you are navigating a new diagnosis or seeking more advanced care after previous treatments have fallen short, our providers stay current with the latest clinical developments to ensure you always have access to the most effective options available.

Ohio Psychiatric Services is the mental health clinic Columbus Ohio families and individuals trust for compassionate, high-quality psychiatric care that is accessible, dignified, and built around the needs of every patient. With convenient locations in Lancaster and Hilliard and telehealth services available for Columbus-area residents, getting the support you need has never been easier. Take the first step toward better mental health today — call [phone] or visit ohiopsychiatricservices.com to schedule your appointment.

[ohiopsychiatricservice]

Trusted TMS Therapy Near Columbus Ohio 

Looking for trusted TMS therapy near Columbus Ohio? Ohio Psychiatric Services is Columbus Ohio's premier destination for advanced Transcranial Magnetic Stimulation (TMS) therapy — a safe, non-invasive, and highly effective treatment for depression, anxiety, OCD, and other treatment-resistant mental health conditions. Their experienced psychiatric team delivers personalized TMS treatment plans in a modern, calm, and welcoming clinical environment right here near Columbus Ohio. Visit ohiopsychiatricservices.com to learn how TMS therapy works and whether it's the right solution for you. At Ohio Psychiatric Services, the most trusted provider of TMS therapy near Columbus Ohio, every patient receives expert, compassionate care with no medication side effects and no downtime. Most major Ohio insurance plans are proudly accepted. Stop struggling alone — visit ohiopsychiatricservices.com or call their Columbus office today to schedule your TMS consultation and take the very first step toward lasting mental wellness.